The current valuation score of Mesoblast Ltd is 9.84, ranking 10 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -18.33, which is -100.00% below the recent high of 0.00 and -35.23% above the recent low of -24.78.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.